Literature DB >> 8566089

Expression and function of Fas antigen on activated murine B cells.

J Wang1, I Taniuchi, Y Maekawa, M Howard, M D Cooper, T Watanabe.   

Abstract

We have studied the expression and function of Fas antigen on murine B lymphocytes. While Fas was present on only a few B cells in the bone marrow, spleen, lymph node or peripheral blood, its expression could be strongly up-regulated by stimulation with soluble CD40 ligand (CD40L). Treatment with anti-IgM and interleukin-4 (IL-4) alone did not induce significant Fas expression but enhanced CD40L-mediated up-regulation of Fas expression. The T cell-derived signal via CD40 is therefore a potent inducer of Fas expression by B lymphocytes. The sensitivity to Fas-mediated apoptosis was found to depend on the duration of B cell activation. B cells activated for 1 day were resistant to Fas-mediated cell death, whereas B cells activated for 3 days were relatively sensitive. Interestingly, different sensitivity to Fas-mediated death signal was observed in 2-day activated B cells. It was found that B cells stimulated with CD40 L alone were more sensitive to Fas-mediated apoptosis than were cells stimulated with CD40L plus anti-IgM or IL-4, and in particular, the combination of the two. The greater sensitivity exhibited by B cells stimulated with CD40L alone seems to be related to limited activation of these cells in the absence of additional stimulation. Co-stimulation of B cells in the presence of CD40L and anti-Fas antibody resulted initially in activation of B lymphocytes, as reflected by the expression of activation markers and cell growth, but this was followed by growth inhibition and cell death. The data demonstrate that the B cell response can be regulated positively and negatively by signaling through CD40 and Fas antigens, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566089     DOI: 10.1002/eji.1830260114

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

Authors:  S Hirose; K Yan; M Abe; Y Jiang; Y Hamano; H Tsurui; T Shirai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Authors:  Jenni E Crowley; Jason E Stadanlick; John C Cambier; Michael P Cancro
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

Review 3.  The role of germinal centers for antiviral B cell responses.

Authors:  M F Bachmann
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

4.  Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity.

Authors:  Yumi Nakayama; Jolanta Kosek; Lori Capone; Eun Mi Hur; Peter H Schafer; Garth E Ringheim
Journal:  J Immunol       Date:  2017-08-28       Impact factor: 5.422

Review 5.  Regulation of autoreactive anti-IgG (rheumatoid factor) B cells in normal and autoimmune mice.

Authors:  H Wang; M J Schlomchik
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

7.  FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival.

Authors:  María C Amezcua Vesely; Marc Schwartz; Daniela A Bermejo; Carolina L Montes; Kelly M Cautivo; Alexis M Kalergis; David J Rawlings; Eva V Acosta-Rodríguez; Adriana Gruppi
Journal:  J Immunol       Date:  2012-04-18       Impact factor: 5.422

8.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Authors:  Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L Telford; Cosima T Baldari; Sergio Romagnani; Antonio Cassone; Mario M D'Elios; Gianfranco Del Prete
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Authors:  Alexandra C Vrazo; Maria Chauchard; Nancy Raab-Traub; Richard Longnecker
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

10.  The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.

Authors:  Gabor Koncz; Anne-Odile Hueber
Journal:  Front Immunol       Date:  2012-07-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.